Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease

Published:2013-03-05 Issue:3 Volume:125 Page:410-419
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Jin Jing¹,Albertz Jennifer¹,Guo Zhihong²,Peng Qi¹,Rudow Gay²,Troncoso Juan C.²,Ross Christopher A.¹³⁴⁵,Duan Wenzhen¹⁴⁵

Affiliation:

1. Division of Neurobiology; Department of Psychiatry and Behavioral Sciences; Johns Hopkins University School of Medicine; Baltimore Maryland USA

2. Division of Neuropathology; Department of Pathology; Johns Hopkins University School of Medicine; Baltimore Maryland USA

3. Departments of Neurology and Pharmacology and Molecular Sciences; Johns Hopkins University School of Medicine; Baltimore Maryland USA

4. Departments of Neuroscience; Johns Hopkins University School of Medicine; Baltimore Maryland USA

5. Program in Cellular and Molecular Medicine; Johns Hopkins University School of Medicine; Baltimore Maryland USA

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.12190/fullpdf

Reference69 articles.

1. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor;Baquet;J. Neurosci.,2004

2. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease;Bithell;Biochem. Soc. Trans.,2009

3. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure;Canto;Curr. Opin. Lipidol.,2009

4. Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model;Carta;Neuroscience,2011

5. Impaired PGC-1alpha function in muscle in Huntington's disease;Chaturvedi;Hum. Mol. Genet.,2009

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment;Acta Pharmaceutica Sinica B;2024-09

2. Exploring the molecular mechanisms of PPARγ agonists in modulating memory impairment in neurodegenerative disorders;Molecular Biology Reports;2024-08-31

3. Mitochondrial targeted antioxidants as potential therapy for huntington’s disease;Pharmacological Reports;2024-07-09

4. Polyglutamine disorders: Pathogenesis and potential drug interventions;Life Sciences;2024-05

5. The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ;eBioMedicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3